Posted by Michael Wonder on 01 Mar 2021
Expanding access to life changing medicines for thousands of Australians
1 March 2021 - How many typos can you spot? I have clocked three.
Thousands of Australians with multiple sclerosis, asthma and diabetes will benefit from the listing or extension of several medications on the Pharmaceutical Benefits Scheme (PBS), bringing further support to patients and their families.
From March 1, Zeposia and Atecture Breezhaler will be listed on the PBS for the first time, and Trulicity will have its PBS listing extended.
